Literature DB >> 9594919

European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel.

H K Biesalski, B Bueno de Mesquita, A Chesson, F Chytil, R Grimble, R J Hermus, J Köhrle, R Lotan, K Norpoth, U Pastorino, D Thurnham.   

Abstract

This article is based on discussions of the lung cancer panel at the Hohenheim Consensus Meeting organized by the World Health Organization and the German Ministry of Health in November 1996. Panel members were international experts in the field of diet and cancer who discussed specific questions relating to lung cancer risk factors and prevention.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9594919     DOI： 10.3322/canjclin.48.3.167

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  25 in total

1.  Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation.

Authors:  Hongqiao Zhang; Honglei Liu; Zea Borok; Kelvin J A Davies; Fulvio Ursini; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

2.  Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk.

Authors:  Timothy R Church; Majda Haznadar; Mindy S Geisser; Kristin E Anderson; Neil E Caporaso; Chap Le; Salwan B Abdullah; Stephen S Hecht; Martin M Oken; Brian Van Ness
Journal:  Int J Mol Epidemiol Genet       Date:  2010-08-05

3.  CUGBP1 promotes cell proliferation and suppresses apoptosis via down-regulating C/EBPα in human non-small cell lung cancers.

Authors:  Haijiao Lu; Zhuang Yu; Shihai Liu; Lianhua Cui; Xiaozheng Chen; Ruyong Yao
Journal:  Med Oncol       Date:  2015-02-21       Impact factor: 3.064

4.  Dihydroartemisinin inhibits cell proliferation via AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells.

Authors:  Kui Liao; Juan Li; Zhiling Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

5.  In vitro effects of mitomycin C on the proliferation of the non-small-cell lung cancer line A549.

Authors:  Qi An; Chao Han; Yubing Zhou; Feng Li; Duolu Li; Xiaojian Zhang; Zujiang Yu; Zhenfeng Duan; Quancheng Kan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Modification of association between prior lung disease and lung cancer by inhaled arsenic: A prospective occupational-based cohort study in Yunnan, China.

Authors:  Yaguang Fan; Yong Jiang; Ping Hu; Runsheng Chang; Shuxiang Yao; Bin Wang; Xuebing Li; Qinghua Zhou; Youlin Qiao
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-04-13       Impact factor: 5.563

7.  Liver kinase B1 promoter CpG island methylation is related to lung cancer and smoking.

Authors:  Rongju Sun; Jie Li; Bo Wang; Yingfei Guo; Lingyun Ma; Xiaojiao Quan; Zhixiang Chu; Tanshi Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis.

Authors:  Mingliang Gu; Xiaoqun Dong; Xuezhi Zhang; Xumin Wang; Yue Qi; Jun Yu; Wenquan Niu
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

9.  CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.

Authors:  Atsuyasu Sato; Norishige Yamada; Yuya Ogawa; Machiko Ikegami
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  The risk of cancer in patients with generalized anxiety disorder: a nationwide population-based study.

Authors:  Cheng-Che Shen; Yu-Wen Hu; Li-Yu Hu; Man-Hsin Hung; Tung-Ping Su; Min-Wei Huang; Chia-Fen Tsai; Shuo-Ming Ou; Sang-Hue Yen; Cheng-Hwai Tzeng; Tzeon-Jye Chiou; Tzeng-Ji Chen; Chia-Jen Liu
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.